FIELD: medicine, pharmaceutics.
SUBSTANCE: invention is related to pharmaceutics and medicine. The composition for urine incontinence contains fragments of viable muscular tissue and a carrier with the fragments of muscular tissue having a particle size from approximately 0.1 to approximately 3 mm3. The method of treating urine incontinence involves injections of the composition into urogenital tissue and into colorectal tissue. The method of preparing the composition involves the stages of producing at least one fragment of viable muscular tissue and combining said fragment with a carrier to be injected into urogenital tissue.
EFFECT: use of the declared invention enables higher clinical effectiveness in urine incontinence, particularly stress-induced urine incontinence ensured by the use of the composition.
12 ex, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING STRESS-INDUCED URINARY INCONTINENCE | 2005 |
|
RU2286790C1 |
| METHOD OF CREATING MODEL FOR STUDYING EFFECTS OF INTRODUCTION OF VOLUME-FORMING SUBSTANCES IN LABORATORY ANIMALS | 2015 |
|
RU2629528C2 |
| METHOD FOR OBTAINING AN INJECTABLE RESORBABLE IMPLANT BASED ON POLYCAPROLACTONE AND MULTIPOTENT STORMAL CELLS FROM UMBILICAL CORD | 2017 |
|
RU2660550C1 |
| NOVEL PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING URINARY INCONTINENCE | 2015 |
|
RU2738886C2 |
| METHODS FOR OBTAINING MUSCLE-DERIVED CELLS | 2018 |
|
RU2796929C2 |
| METHOD OF RESIDUAL URINARY INCONTINENCE TREATMENT AFTER IMPLANTATION OF ARTIFICIAL URINARY SPHINCTER | 2015 |
|
RU2610000C2 |
| CYSTOSCOPIC TREATMENT OF HORMONE-DEPENDENT SPHINCTER INSUFFICIENCY OF THE BLADDER IN FEMALE DOGS | 2021 |
|
RU2755278C1 |
| METHOD FOR NONSURGICAL TREATMENT OF STRESS AND MIXED URINE INCONTINENCE IN FEMALES BY FOCUSED ULTRASOUND | 2019 |
|
RU2710858C1 |
| PDE INHIBITORS AND THEIR COMBINATIONS FOR TREATMENT OF UROLOGIC DISORDERS | 2006 |
|
RU2435588C2 |
| METHODS OF TREATING UROLOGICAL DISORDERS USING SELECTIVE ANDROGEN RECEPTOR MODULATORS | 2015 |
|
RU2691652C2 |
